FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Malaria | Vaccine | Mymetics | Christian Rochet

Mymetics outlines malaria vaccine approval timeline

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools
  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

Switzerland's Mymetics says that its experimental malaria vaccine could be ready for marketing as early as 2014. CEO Christain Rochet says that clinical trials on the vaccine--obtained from Pevion--have been carried out in Britain and Switzerland as well as developing nations. It should take another three years to complete clinical work on the vaccine, says Rochet, leading the company to conclude that marketing approval could come in six years.

"There is a pressing need for a vaccine against malaria," said the CEO. "Up to 500 million people a year are infected, with a mortality rate of approximately two million each year."

- read the AFP report

Related Articles:
Malaria trials will pay volunteers to get infected
Gates Foundation readies $258M for new malaria programs
Has the Gates Foundation created a malaria 'cartel'?


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Malaria   Vaccine   Mymetics   Christian Rochet